Use of oral melatonin in recalcitrant melasma

International Journal of DermatologyEarly View Letter to the Editor Use of oral melatonin in recalcitrant melasma Rashmi Sarkar, Corresponding Author Rashmi Sarkar [email protected] orcid.org/0000-0001-8768-4879 Lady Hardinge Medical College and Maulana Azad Medical College, New Delhi, India Correspondence Rashmi Sarkar Lady Hardinge Medical College and Associated Hospitals New Delhi India E-mail: [email protected]Search for more papers by this authorBharati Verma, Bharati Verma Lady Hardinge Medical College and Maulana Azad Medical College, New Delhi, IndiaSearch for more papers by this authorVibhu Mendiratta, Vibhu Mendiratta Lady Hardinge Medical College and Maulana Azad Medical College, New Delhi, IndiaSearch for more papers by this author Rashmi Sarkar, Corresponding Author Rashmi Sarkar [email protected] orcid.org/0000-0001-8768-4879 Lady Hardinge Medical College and Maulana Azad Medical College, New Delhi, India Correspondence Rashmi Sarkar Lady Hardinge Medical College and Associated Hospitals New Delhi India E-mail: [email protected]Search for more papers by this authorBharati Verma, Bharati Verma Lady Hardinge Medical College and Maulana Azad Medical College, New Delhi, IndiaSearch for more papers by this authorVibhu Mendiratta, Vibhu Mendiratta Lady Hardinge Medical College and Maulana Azad Medical College, New Delhi, IndiaSearch for more papers by this author First published: 22 April 2024 https://doi.org/10.1111/ijd.17201Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Daroach M, Vinay K, Bishnoi A, Parsad D, Kumaran MS. Extrafacial melasma: a scenario less explored. Indian Dermatol Online J. 2022; 13(4): 484–486. 10.4103/idoj.idoj_463_21 PubMedGoogle Scholar 2McKesey J, Tovar-Garza A, Pandya AG. Melasma treatment: an evidence-based review. Am J Clin Dermatol. 2020; 21(2): 173–225. 10.1007/s40257-019-00488-w PubMedWeb of Science®Google Scholar 3Sarkar R, Devadasan S, Choubey V, Goswami B. Melatonin and oxidative stress in melasma—an unexplored territory; a prospective study. Int J Dermatol. 2020; 59(5): 572–575. 10.1111/ijd.14827 CASPubMedWeb of Science®Google Scholar 4Hamadi SA, Mohammed MM, Aljaf AN, Abdulrazak A. The role of topical and oral melatonin in management of melasma patients. Arab J Basic Appl Sci. 2009; 8: 30–42. Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation